← All ideas

Every session tells a story

Longitudinal Therapy OutcomesData Platform

A user-generated business concept from Nowen — not an existing product.

Log your therapy sessions and track what's actually working across diagnoses and settings—while insurers and software companies fund the app by learning which interventions help patients thrive.

Because every child's progress deserves to be seen, measured, and celebrated.

How it works

Speech-language pathologists log therapy sessions and patient progress milestones for free. The platform aggregates and anonymizes this data, then sells quarterly outcome reports to health insurers (analyzing intervention efficacy by diagnosis and geography) and product-market fit insights to SLP software vendors (showing which tools correlate with outcomes).

Story

For speech-language pathologists, who struggle to track longitudinal patient outcomes across interventions and settings, the app logs therapy sessions and patient progress milestones, free forever because insurers and clinical software vendors pay for anonymized outcome reports

Payer

Health insurers pay $15K-25K per quarterly report on intervention efficacy by diagnosis code and geography; SLP software vendors pay $10K/mo for product-market fit data on which tools correlate with outcomes; both are buying access to the anonymized longitudinal outcome dataset that the therapist community creates

Asset

Longitudinal speech therapy outcome data across diverse interventions, patient populations, and settings; engaged SLP community creating trusted benchmarks

Revenue potential

$6KLow$22KMid$54KHigh

We model the payer as insurers and software vendors combined, estimating around 800 reachable organizations (roughly 600 regional and national health insurers plus 200 SLP software vendors, clinics, and research institutions). Annual contract value is set at $18K, the midpoint of the stated quarterly report range annualized. Market penetration is very conservative at 0.3 to 2.5 percent over several years, reflecting deep skepticism that payers will purchase data they already access via claims or internal product analytics. We assume only a 15 percent capture rate because the business competes with free claims data for insurers and internal user telemetry for vendors, leaving little willingness to pay for anonymized third-party benchmarks.

Competition  Competitive

The SLP software space has established practice management platforms (Sprypt, TheraPlatform, SLPFlow) offering scheduling, documentation, billing, and insurance filing. These incumbents already capture therapy session data as part of their core workflow, making a standalone outcome-tracking tool redundant unless it integrates deeply. The proposed data monetization model conflicts with existing claims data flows to insurers and raises competitive dynamics that undermine vendor willingness to pay.

  • Sprypt — Speech therapy practice management software offering scheduling, documentation, and billing · source
  • TheraPlatform — SLP billing and practice management platform with HIPAA-compliant video, scheduling, documentation, and insurance filing · source
  • SLPFlow — SLP software provider offering practice management tools; positions itself as helping practices choose appropriate software · source

Wedge

No credible wedge evident. Incumbents already handle documentation and billing; layering a separate outcome-tracking tool creates adoption friction. The data monetization model faces structural barriers: vendors are unlikely to pay for insights that help competitors, insurers already receive claims data directly, and HIPAA-compliant anonymization at scale requires costly infrastructure and legal review that free tools cannot sustain. Without exclusive data agreements or regulatory mandate, the dataset lacks defensible value.

Sources

Industry

Speech-Language Pathology

Market: S · up to 1KFriction: lowCapital: lowweak: anonymized data reportsUnique asset

Reserved by its author until 8/8/2026.